Free Trial

Oxford Instruments plc (LON:OXIG) Insider Buys £160.08 in Stock

Oxford Instruments logo with Computer and Technology background

Oxford Instruments plc (LON:OXIG - Get Free Report) insider Gavin Hill purchased 8 shares of the stock in a transaction dated Friday, January 10th. The shares were acquired at an average price of GBX 2,001 ($24.43) per share, for a total transaction of £160.08 ($195.43).

Gavin Hill also recently made the following trade(s):

  • On Monday, November 11th, Gavin Hill bought 7 shares of Oxford Instruments stock. The stock was acquired at an average price of GBX 2,122 ($25.91) per share, with a total value of £148.54 ($181.35).

Oxford Instruments Stock Performance

OXIG stock traded down GBX 27.33 ($0.33) during trading hours on Monday, reaching GBX 1,956 ($23.88). The stock had a trading volume of 70,947 shares, compared to its average volume of 321,455. The stock has a market capitalization of £1.14 billion, a PE ratio of 2,274.42, a price-to-earnings-growth ratio of -3.56 and a beta of 0.96. The stock has a 50-day simple moving average of GBX 2,095.85 and a 200 day simple moving average of GBX 2,202.25. Oxford Instruments plc has a fifty-two week low of GBX 1,870 ($22.83) and a fifty-two week high of GBX 2,765 ($33.76). The company has a debt-to-equity ratio of 12.96, a current ratio of 1.64 and a quick ratio of 1.11.

Oxford Instruments Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, January 10th. Stockholders of record on Thursday, November 28th were paid a dividend of GBX 5.10 ($0.06) per share. This represents a dividend yield of 0.24%. The ex-dividend date was Thursday, November 28th. Oxford Instruments's dividend payout ratio is presently 2,441.86%.

Analyst Upgrades and Downgrades

OXIG has been the topic of a number of research reports. Shore Capital reaffirmed a "buy" rating on shares of Oxford Instruments in a research report on Wednesday, October 16th. Berenberg Bank reduced their target price on shares of Oxford Instruments from GBX 2,925 ($35.71) to GBX 2,830 ($34.55) and set a "buy" rating for the company in a research note on Tuesday, November 12th.

Read Our Latest Analysis on Oxford Instruments

About Oxford Instruments

(Get Free Report)

Oxford Instruments provides academic and commercial organisations worldwide with market-leading scientific technology and expertise across its key market segments: materials analysis, semiconductor, and healthcare & life science. Innovation is the driving force behind Oxford Instruments' growth and success, supporting its core purpose to accelerate the breakthroughs that create a brighter future for our world.

See Also

Insider Buying and Selling by Quarter for Oxford Instruments (LON:OXIG)

Should You Invest $1,000 in Oxford Instruments Right Now?

Before you consider Oxford Instruments, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Instruments wasn't on the list.

While Oxford Instruments currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Related Videos

3 Stocks Insiders Are Selling, But Analysts Still Love
NVIDIA Unveils Game-Changing Tech, But Stock Dips
The Future of Healthcare: 3 AI Stocks Leading the Way

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines